Abstract: Cationic liposome-DNA complexes, also called "lipoplexes", constitute a potentially viable alternative to viral vectors for the delivery of therapeutic genes. Here we review the mechanisms of lipoplex-mediated gene delivery and barriers to efficient gene expression, novel cationic lipids used for transfection, and methods for enhancing gene transfer via the use of proteins, including transferrin, albumin and asialofetuin, and synthetic peptides, including GALA and nuclear localization signal peptides. We underscore the importance of understanding the mechanisms of cytoplasmic and nuclear entry of DNA and its dissociation from lipoplexes. We emphasize that the in vitro transfection activity of new lipoplex constructs should be tested in the presence of high serum concentrations.
INTRODUCTION
Cationic liposome-DNA complexes ("lipoplexes") constitute a potentially viable alternative to viral gene delivery vehicles [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . We have summarized previously the advantages and limitations of viral vectors and lipoplexes [7, 11] . We have also reviewed the early studies with lipoplexes in cell culture, in animal models and humans [11] . In the accompanying article we have discussed the structureactivity relationship of cationic liposoomes, the roles of colipids, the lipid:DNA charge ratio, and the mode of lipoplex preparation in transfection, interaction of lipoplexes with serum components, and the effects of storage conditions on the activity of lipoplexes [12] . Here we will focus our attention on the mechanisms of lipoplex-mediated transfection, some new cationic liposomes, and on the enhancement of lipoplex-mediated gene transfer by proteins and peptides, particularly in the presence of serum.
MECHANISMS OF LIPOPLEX-MEDIATED GENE DELIVERY
Successful gene delivery via lipoplexes is thought to require several conditions to be met: (i) condensation of DNA into the lipoplex structure and its protection from The adhesion of the lipoplexes to the cell membrane is mediated by electrostatic interactions. Although cell surface heparin/heparan sulfate-containing proteoglycans are thought to be involved in this step [13, 14] , proteoglycan-deficient cells were found to internalize lipoplexes as efficiently as wild-type cells [15] . Cationic liposomes appear to bind to trypsin-sensitive proteins on macrophage-like cells, but not to glycosaminoglycans or neuraminic acid [16] .
Lipoplexes are thought to be internalized primarily via endocytosis involving coated or uncoated endocytotic vesicles [17] [18] [19] [20] [21] [22] [23] [24] , although fusion of lipoplexes with the plasma membrane [1, 7, 23] or endocytotic vesicles [25] has also been observed. Membrane fusion, monitored by lipid mixing between lipoplexes and cellular membranes does not appear to correlate well with transfection [23, 26] . Nevertheless, the endoscytotic membrane has to be destabilized for the lipoplex or DNA to enter the cytoplasm before confronting lysosomal enzymes. Internalized lipoplexes are likely to destabilize the membrane of endocytotic vesicles and to induce the transbilayer movement of anionic lipids from the cytoplasmic leaflet to the lumenal leaflet [18] . The interaction between anionic and cationic lipids may lead to the displacement of DNA from the lipoplex and its release into the cytoplasm. Support for this hypothesis is provided by the observations that dioleoylphosphatidylethanolamine (DOPE)-containing cationic lipid/oligonucleotide complexes undergo lipid mixing with endocytotic vesicles [25] or transfer the oligonucleotide into the nucleus [27] , and that endosomes are destabilized by various lipoplexes [28] . We have proposed that pore formation in the endosome may be an alternative mechanism of escape of the complexes or of free DNA into the cytoplasm [7] .
Following entry into the cytoplasm, the DNA has to be transported to the nucleus without being degraded [29] , possibly by continued complexation with cationic lipid, and must pass through the nuclear membrane. The studies of Zabner et al. [17] and Labat-Moleur et al. [30] have indicated that the nuclear membrane is a major barrier to lipoplex-mediated gene delivery to the nucleus. Nuclear localization of delivered plasmids appears to correlate with the differential level of transgene expression in different cells [31] . It is not known whether DNA penetrates the nuclear membrane through pores via passive diffusion or active transport via non-specific association with receptors for nuclear localization signal (NLS) peptides. Thus, proliferating cells that lose the integrity of their nuclear membrane during mitosis are transfected more readily compared to non-dividing primary cells [32] . After entering the nucleus the DNA must dissociate considerably from cationic lipids to become active transcriptionally, as indicated by experiments in which lipoplexes were microinjected into oocyte nuclei [17] . The longevity of the DNA in the nucleus is also an important factor in transgene expression. Normal human fibroblasts, which are difficult to transfect, eliminate rapidly exogenous DNA from the nucleus, while in readily transfected HeLa cells plasmid DNA retains stability in the nucleus of for long periods [33] .
NOVEL CATIONIC LIPIDS
We have reviewed previously most of the early studies with various cationic lipids, particularly those that are readily available commercially [7, 11] . In this section we will describe studies with novel cationic lipids that have been described relatively recently.
Kikuchi et al. [34] have shown that liposomes containing the cationic lipid O,O-ditetradecanoyl-N-(α -trimethylammonioacetyl) diethanolamine chloride (DC-6-14) and DOPE or cholesterol as helper lipid, exhibit high transfection efficiency in disseminated peritoneal tumour cells, and are more efficient than commercial cationic liposomes such as Lipofectin, Lipofectace and Lipofectamine. These liposomes were resistant to the presence of low concentrations (5%) of serum [35] . Cationic liposomes composed of the phosphatidylcholine derivative, 1,2-dioleoyl-sn-glycero-3-ethylphosphatidylcholine mediate transfection of cultured cells even after being incubated with 95% serum, indicating that the lipid-DNA complex does not dissociate or destabilize under these conditions [36] . Doubly positively charged, amphiphilic 1,4-dihydopyridine derivatives containing C12 alkyl chains have considerably higher transfection acitivities than DOTAP in two cell lines tested [37] . The spermine-based 1,3-dioleoyloxy-2-(N 5 -carbamoyl-spermine)-propane (DOCSPER) has transfection activity equivalent to, and toxicity significantly lower than, Lipofectin [38] .
New cationic lipids rac-[(2,3-dioctadecyloxypropyl)(2-hydroxyethyl)]-dimetylammonium chloride (CLIP-1) and rac-[2(2,3-dihexadecyloxypropyl-oxymethyloxy)ethyl]trime-
tylammonium bromide (CLIP-6) have been tested for transfection activity in vitro along with CLIP-9. These cationic lipids constitute a set of cationic "rulers" with different linkers between the hydrophobic and polar moieties: 1 chemical bond (CLIP-1), 6 bonds (CLIP-6) and 9 bonds (CLIP-9) [39] . For the cell lines used in this study, transfection activity increases with the length of the linker region. Glycyrrhizin or the α-tocopherol ester of succinic acid [40] are included as pH-sensitive agents and fusogenes in the liposome composition.
Carbohydrate-conjugated polycations or lipids are probably the most effective transfection system for receptormediated transfer. Liposomes containing a cationic glycolipid, with a glucose residue between the cationic and hydrophobic parts of the lipid molecule (GLYCOCLIP) have been used for transfection of CHO cells [41] . Mixed liposomes of GLYCOCLIP, a monocholesterol derivative of hexaethyleneimine (CHOLENIM) and DOPE exhibit a 10-fold higher transfection activity than GLYCOCLIP/DOPE, comparable to commercial preparations of the "DOSPER" type. Monocationic lipids containing xylitol formulated with cholesterol also transfect COS-1 cells to levels higher than that obtained with Lipofectamine [42] , although the two types of lipid have not been tested side-by-side.
ENHANCEMENT OF LIPOPLEX-MEDIATED GENE DELIVERY BY PROTEINS
Among the strategies employed to enhance lipoplexmediated transgene expression in mammalian cells are (i) the attachment of targeting ligands to promote cell binding and receptor-mediated endocytosis, (ii) the use of synthetic membrane-active peptides to induce the destabilization of endosomes and release of the genetic material into the cytoplasm, (iii) the use of cationic polypeptides to condense DNA thereby enhancing serum resistance and reducing the size of the complexes, (iv) the association of albumin with cationic liposomes to confer serum resistance and enhanced gene transfer, and (v) the complexation or covalent attachment of NLS peptides to mediate the nuclear localization of the plasmid.
The inclusion of a trigalactolipid [43] or galactosylated cholesterol derivatives [44] in cationic liposomes enhances the transfection of HepG2 hepatoma cells bearing the asialoglycoprotein receptor, compared to plain lipoplexes. An integrin-targeting peptide enhances the transfection activity of lipoplexes by two orders of magnitute in a variety of cell lines [45] . The use of asialofetuin associated with lipoplexes increases DNA delivery to cultured cells expressing the asialoglycoprotein receptor and to the the liver [46] [47] [48] . Delivery of the interleukin-12 gene to experimental hepatocellular carcinoma tumors via asialofetuin-lipoplexes results in the expression of interleukin-12 and interferon-γ in serum, and a significant reduction of the tumor size, while plain lipoplexes are less Ternary complexes of transferrin, cationic liposomes and DNA, prepared by first associating transferrin with cationic liposomes followed by complexation with DNA, greatly enhance the transfection of a variety of cells, including lymphocytes and macrophages [49] [50] [51] [52] [53] [54] . At a particular ratio of transferrin, DNA and cationic lipid (12.5 µg:1 µg:10 nmol, which corresponds to a charge ratio (+/-) of 1.67), the complexes form a compact structure of 50-90 nm, with transferrin molecules decorating the surface, resembling a virus particle with a dense core [55] . We should note, however, that much higher lipoplex sizes may be obtained (600 nm) at similar ratios (1:1 and 2:1) at an optimized transferrin concentration (32 µg) [22] . Transferrin-lipoplexes are internalized by endocytosis, as shown by the effect of endocytosis inhibitors, and the inhibition of endosome acidification or non-coated pit-meadiated endocytosis blocks partially the transfection activity. Studies on the kinetics of lipoplex-cell interactions show that association of transferrin with lipoplexes increases the extent of fusion with endosomes [56] . This observation supports the hypothesis that transferrin becomes fusogenic under acidic conditions, exposing hydrophobic domains, and thus facilitating the disruption of endosome membranes and the intracellular release of DNA [22, 56] . Fluorescence microscopy of cells incubated with fluorescent lipoplexes also indicate that drugs that prevent acidification of the endosome lumen inhibit significantly the extent of release of complexed DNA into the cytoplasm (P. Pires, S. Simões, N. Düzgünes and M.C. Pedroso de Lima, unpublished data).
Although the presence of high concentrations of serum (60%) can inhibit drastically transfection by plain lipoplexes, transferrin-lipoplexes are resistant to the inhibitory effects of serum, particularly at higher charge ratios (2/1 and 4/1 (+/-)) [54] . Transfection is even enhanced by serum at the 4/1 charge ratio. In some cell types, even 1/2 and 1/1 (+/-) transferrin lipoplexes show significant transfection in the presence of 60% serum [57] . While previous studies had indicated that increasing the charge ratio of lipoplexes can overcome the inhibitory effects of serum, the highest serum concentration utilized was 20% [58] . The molecular basis of the serum resistance and the enhancement by serum is not understood completely. It is likely that the interaction of transferrin-lipoplexes with cell surface receptors facilitates their uptake by host cells, while plain lipoplexes are coated with serum proteins and are inhibited from interacting electrostatically with the cell surface. In addition, the presence of a transferrin coat on lipoplexes may hinder the complexation of serum proteins with cationic lipids.
Preincubation of the complexes for 6 h before addition to cells not only enhances transfection by complexes at all charge ratios, but also confers serum resistance to the complexes with 1/1 charge ratio [54] , which are net negatively charged [50] . This preincubation most likely facilitates the completion of the complexation reaction, a process termed "maturation" [59] , presenting a structure more resistant to the destabilizing effects of serum.
Transferrin-targeted lipoplexes have been used to transfect a high percentage (60%) of endothelial cells derived from heart tissue [60] . Gene delivery to the corneal endothelium can also be achieved by transferrin-lipoplexes [61] . In hippocampal neurons, much higher levels of transfection are obtained by transferrin-lipoplexes, than with plain lipoplexes, particularly at the 1/1 and 4/1 (+/-) charge ratios (T. Giraõ de Cruz, S. Simões, and M. C. Pedroso de Lima, unpublished data) (Figure 1 ) Primary hepatocytes and adipocytes show significant transgene expression following treatment with transferrin-lipoplexes in the presence of high concentrations of serum [57] . Transferrin-lipoplexes have been utilized for delivering the genes for ß-galactosidase and the tumor suppressor protein p53 to xenograft tumors of human squamous cell carcinoma cells (JSQ-3) in nude mice. About 20-30% of the cells in the tumor are transfected [62] . Intravenous delivery of the p53 gene renders the tumor cells sensitive to radiotherapy, and results in complete tumor regression. Similarly, human prostate cancer cell (DU145) xenografts can be treated effectively with a combination of p53 gene delivery in transferrin-lipoplexes and radiation therapy, while radiation therapy alone and p53 delivery via plain lipoplexes are ineffective [55] . The delivery of the p53 gene using lipoplexes incorporating a single-chain, antitransferrin receptor antibody via a biosynthetically incorporated lipid anchor, results in improved tumor cell binding and gene expression, as well as improved efficacy in a breast cancer metastasis model [63] . We have utilized transferrin-lipoplexes to deliver the Herpes Simplex virus thymidine kinase gene (HSV-tk) to HSC-3 and H413 human squamous cell carcinoma cells. Treatment of the transfected cells with ganciclovir results in significant cytotoxicity [64] (Figure 2) .
In addition to the use of receptor-ligands such as transferrin, association of apo-transferrin or human serum albumin can also enhance the transfection activity of lipoplexes [22, 65, 66] . Similar to the transferrin-lipoplexes, albumin-lipoplexes have optimal activity at the 1/1 charge ratio in the absence of serum, under which conditions they are net negatively charged. These complexes are also resistant to the inhibitory effects of serum, and enhance gene delivery in vivo compared to plain lipoplexes. As with transferrin, albumin may acquire fusogenic properties at acidic pH [67] [68] [69] , and facilitate the destabilization of endosomal membranes, possibly resulting in the transbilayer movement of acidic phospholipids from the cytoplasmic lumen. This, in turn, may mediate the dissociation of the DNA from the cationic lipids and the entry of DNA into the cytoplasm [70] . We have recently utilized albuminlipoplexes to deliver the HSV-tk gene to HSC-3 cells, and have shown that ganciclovir treatment of these cells causes enhanced cytotoxicity compared to plain lipoplexes (A. Kim, J. Monzon-Duller, K. Konopka and N. Düzgünes, unpublished data).
Interaction of poly(L-lysine) with DNA reduces the particle size of lipoplexes, renders the DNA resistant to nucleases and enhances transfection activity [71] . Likewise, complexation of DNA with the polycationic peptide, protamine sulfate, followed by addition of cationic liposomes enhances gene expression in cultured cells compared to the plain lipoplexes [72] . This enhancement may be attributed to the condensing effect of protamine on DNA, and to the presence of NLS sequences in protamine. High levels of gene expression are also observed in mice with cationic lipid-protamine-DNA complexes compared to plain lipoplexes [73] . When the complexes are prepared by the addition of protamine sulfate to cationic liposomes followed by addition of DNA in vivo gene expression is even higher [74] . The in vivo transfection efficacy of cationic lipid-protamine-DNA complexes is enhanced further by the use of cholesterol instead of DOPE as a helper lipid in cationic liposomes.
The use of both a targeting ligand (transferrin) and a condensing agent (protamine) results in an enhancement of gene delivery at an optimal protamine concentration [57] . When protamine and transferrin are first incubated with cationic liposomes and the resulting complex mixed with DNA, higher levels of transfection are achieved compared to complexes prepared by the mixture of protamine-condensed DNA with transferrin-complexed cationic liposomes. Protamine-transferrin-DNA complexes prepared in this way are also more effective than plain or transferrin-lipoplexes when administered intravenously. This is particularly pronounced in the liver and spleen [57] .
We have shown recently that protamine also enhances gene delivery by asialofetuin-lipoplexes targeted to cells expressing the asialoglycoprotein receptor, both in vitro and in vivo [48] (Figure 3) . The complexes with protamine have a significantly smaller size compared to the asialofetuinlipoplexes, which may facilitate gene expression in hepatocytes.
ENHANCEMENT OF LIPOPLEX-MEDIATED GENE DELIVERY BY PEPTIDES
The use of peptides that can destabilize endosomes or facilitate the fusion of lipoplexes with the endosome membrane can enhance gene delivery. Kamata et al. [75] first reported that anionic or cationic derivatives of the Nterminal peptide of the HA2 subunit of the influenza virus fusion protein, hemagglutinin, enhance transfection by Lipofectin by a factor of 2-7. The addition of the hemagglutinin-derived peptide INF6 to pre-formed lipoplexes of Transfectam (lipopolyamine) enhances transfection by up to 1000-fold [76] . A 10-fold enhancement of gene expression is obtained via the association of the pHsensitive peptide GALA [77, 78] with DOTAP/DOPE (1:1) liposomes before complexation with DNA, at a charge ratio of 1:1 (+/-) [50] . For net negatively charged complexes (1:2), the enhancement in transfection is by several orders of magnitude, particularly since gene transfer by plain lipoplexes at this charge ratio is very limited. The combined use of GALA and transferrin or albumin causes considerably higher levels of transfection in primary, non-dividing human macrophages compared to plain lipoplexes or ternary lipoplexes containing only transferrin or albumin [51, 65] .
NLS peptides consist of a short stretch of basic amino acids in certain proteins and direct them to the nucleus through nuclear pore complexes. DNA-NLS peptide complexes associated with cationic liposomes were shown to mediate an 8-fold enhancement at the optimal peptide concentration, compared to plain lipoplexes [79] . The association of a NLS peptide with DOTAP/DOPE-DNA complexes enhances transfection in SKnSH cells by about 3-fold [80] . Zanta et al. [81] have shown that covalent coupling of a single NLS sequence to capped DNA containing a hairpin oligonucleotide enriched with amino groups, results in a dramatic enhancement in the transfection of a variety of cell types, including non-dividing cells, even with small amounts of DNA. A bifunctional peptide nucleic acid (PNA)-NLS peptide conjugate can be hybridized with certain sites in the plasmid and facilitate the transport of DNA into the nucleus [82] . Lipoplexes containing a plasmid incorporating the SV40 enhancer/promoter region and Lipofectin enhance gene expression in non-dividing CV1 cells by 500-fold compared to lipoplexes containing only the CMV promoter [83] . It is thought that the interaction of cellspecific transcription factors with promoters on the plasmid facilitates the nuclear import of the complex. In another approach to nuclear targeting, the M9 sequence of heterogeneous nuclear ribonucleoprotein (hnRNP) A1 is conjugated to a cationic peptide scaffold derived from a scrambled sequence of the SV40 T-antigen consensus NLS to facilitate its binding to DNA [84] . Delivery of this construct using Lipofectamine enhances by more than 60-fold the transfection activity in primary endothelial cells. The use of this "non-classical" NLS for tranfection of primary neurons and neuronal cell lines results in 20-100-fold higher gene expression compared to plain lipoplexes [85] .
CONCLUDING REMARKS
Much progress has been made in the development of cationic liposomes for gene delivery to mammalian cells in vitro and in vivo [7] [8] [9] 11, 12] since they were first described by Felgner et al. (1987) [1] . These developments include the generation of numerous novel cationic lipids, the enhancement of transfection activity and efficiency by improved plasmid expression systems and by novel constructs involving both lipids and proteins or peptides. We have described some of these developments in this and the accompanying review [12] , and elsewhere [7, 9, 11] . It is apparent that the new generation lipoplexes have impoved transfection efficiencies in vitro and in vivo, and in some cases this has translated into improved therapeutics in animal models. We have emphasized previously the importance of testing new lipoplex constructs in vitro in serum containing media, preferably at high concentrations emulating in vivo conditions, before extensive experiments are undertaken in animals [11] . At this stage, we believe it is important to understand the molecular details of how lipoplexes behave in serum-containing media, in vivo, and inside cells. We need to understand how lipoplexes destabilize endocytotic vesicle membranes, in what form they are delivered into the cytoplasm, how they are transported to the nucleus, how they enter the nucleus, and how and what stage DNA dissociates from its vector. Understanding these steps will enable us to establish a balance between protecting DNA by condensing agents and enabling it to dissociate from the agents once inside the nucleus. A clear view of the mechanisms of nuclear entry will facilitate the development of methods by which this step can be facilitated. Establishing the factors that contribute to serum inhibition of transfection will help in the design of more serum-resistant lipoplexes. With the emerging complications of viral vectors in gene therapy applications in humans, including toxicity and immunogenicity, new generation lipoplexes will undoubtedly find their place in successful gene therapies.
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